Vivace Ultra Receives FDA Clearance

Vivace Ultra by Aesthetics Biomedical has been cleared by the FDA for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. The Vivace Ultra combines radiofrequency microneedling and ultrasound imaging and mapping. The product also has insulated and non-insulated needle, four delay speed, and is effective on all skin types. A radiofrequency clinical study found that 95 percent of patients noticed an improvement in skin texture after a series of treatments between 2 to 6 sessions.